ROSE during EBUS-TBNA yielded high sensitivity and overall accuracy, demonstrated strong sample adequacy, and showed substantial concordance with the final pathology. Optimizing the number of passes and considering LN size can enhance adequacy, and recognizing the limitations of cytological subtyping and potential observer variability is essential for multidisciplinary decision-making.
Karataş et al. (Tue,) studied this question.